Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
This Is the Biggest Company Not in the "Magnificent Seven" -- but It Deserves to Be
04:55am, Monday, 04'th Mar 2024
The approval of Zepbound as a weight-loss drug is proving to be a game changer for Eli Lilly. While the valuation is a bit pricey, interested investors might want to wait for a better entry point.
Better Blockbuster-Drug Stock: Novo Nordisk vs. Eli Lilly
12:51pm, Sunday, 03'rd Mar 2024
Blockbuster drugs can be disproportionately beneficial for biopharmas. Novo Nordisk is already squeezing a lot of cash out of semaglutide.
Better Buy: Eli Lilly vs. Viking Therapeutics
09:35am, Sunday, 03'rd Mar 2024
Eli Lilly's prospects look solid thanks to a key medicine, a solid lineup, and a deep pipeline. Viking Therapeutics' shares could skyrocket (again) on positive clinical developments.
3 Magnificent Growth Stocks to Buy in March
09:30am, Saturday, 02'nd Mar 2024
Eli Lilly could have the world's future best-selling drug in its lineup. Moderna is poised to expand beyond COVID with several new products potentially on the way.
Is It Too Late to Buy Eli Lilly Stock Now?
08:15am, Saturday, 02'nd Mar 2024
Eli Lilly dominated 2023 thanks in large part to Mounjaro, its flagship diabetes medication. The pharma giant also has multibillion-dollar drugs in cancer, plaque psoriasis, and more.
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion
11:35am, Friday, 01'st Mar 2024
Lilly's new weight-loss drug could top $62 billion in 2030 sales, an analyst said Friday as he boosted his price target on Eli Lilly stock to 1,000.
3 Stocks Showing Constructive Pullbacks with Indexes at New Highs
11:12am, Friday, 01'st Mar 2024
One of the most exciting things for an investor or trader is to look at tier account statement, or at the charts of what they own, and see a stock like Nvidia Corp. NASDAQ: NVDA or even the broader SP
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
08:45am, Friday, 01'st Mar 2024
Eli Lilly has been one of the hottest names in healthcare thanks to its anti-obesity and diabetes treatments. TransMedics has been more than doubling sales and expects around 50% revenue growth this y
These 4 Stocks Are the "Magnificent Seven" of Healthcare
01:59am, Friday, 01'st Mar 2024
The Magnificent Seven are stealing the show this year on the market. They're all technology companies -- but there are opportunities elsewhere, too.
Eli Lilly and Novo Nordisk will remain leaders in the weight-loss drug market: Mizuho's Jared Holz
01:40pm, Thursday, 29'th Feb 2024
CNBC's Melissa Lee and Jared Holz, Mizuho Securities America healthcare sector strategist, join 'Squawk on Street' to discuss the weight-loss drug market, why he believes Eli Lilly and Novo Nordisk wi
Stock Splits Watch: 3 Likely Candidates to Keep on Your Radar in 2024
05:20pm, Wednesday, 28'th Feb 2024
While stock splits don't necessarily change the valuation of a company's stock. They do offer some benefits.
Best performing S&P 500 stocks in 2024
09:08am, Wednesday, 28'th Feb 2024
As March 2024 draws near, the performance of the S&P 500 Index is starting to reveal itself, with some stocks demonstrating notable growth while others show potential for valuation increases in the mo
Exclusive: Lilly CEO says its obesity drug could enter India as early as 2025
01:43am, Wednesday, 28'th Feb 2024
Eli Lilly 's CEO David Ricks told Reuters on Wednesday that the U.S. drugmaker expects to launch its obesity drug in Indian market as early as next year.
Why Novo Nordisk and Eli Lilly Stocks Slipped Today
06:01pm, Tuesday, 27'th Feb 2024
A rival's weight-loss drug candidate did well in a mid-stage clinical trial. The treatment met all of its endpoints in the study.
Calls of the Day: Some bullish calls on Netflix, Eli Lilly, General Electric and Snowflake
02:09pm, Tuesday, 27'th Feb 2024
The Investment Committee debates how to trade these names: Netflix, Eli Lilly, General Electric and Snowflake.
